F m Investments LLC Has $4.88 Million Stock Position in Merit Medical Systems, Inc. $MMSI

F m Investments LLC reduced its stake in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 19.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 55,306 shares of the medical instruments supplier’s stock after selling 13,407 shares during the quarter. F m Investments LLC’s holdings in Merit Medical Systems were worth $4,875,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in the business. Blue Trust Inc. lifted its stake in Merit Medical Systems by 11.0% in the fourth quarter. Blue Trust Inc. now owns 1,853 shares of the medical instruments supplier’s stock valued at $163,000 after buying an additional 184 shares during the period. First Horizon Corp lifted its stake in Merit Medical Systems by 19.7% in the fourth quarter. First Horizon Corp now owns 1,117 shares of the medical instruments supplier’s stock valued at $98,000 after buying an additional 184 shares during the period. CANADA LIFE ASSURANCE Co lifted its stake in Merit Medical Systems by 0.4% in the third quarter. CANADA LIFE ASSURANCE Co now owns 50,667 shares of the medical instruments supplier’s stock valued at $4,095,000 after buying an additional 189 shares during the period. CWM LLC lifted its stake in Merit Medical Systems by 12.9% in the third quarter. CWM LLC now owns 2,072 shares of the medical instruments supplier’s stock valued at $172,000 after buying an additional 237 shares during the period. Finally, Arizona State Retirement System lifted its stake in Merit Medical Systems by 1.4% in the third quarter. Arizona State Retirement System now owns 17,477 shares of the medical instruments supplier’s stock valued at $1,455,000 after buying an additional 246 shares during the period. 99.66% of the stock is owned by institutional investors and hedge funds.

Merit Medical Systems Price Performance

Shares of NASDAQ:MMSI opened at $61.27 on Friday. The company has a quick ratio of 3.46, a current ratio of 5.08 and a debt-to-equity ratio of 0.45. Merit Medical Systems, Inc. has a twelve month low of $59.74 and a twelve month high of $100.19. The stock’s 50 day moving average is $69.44 and its 200-day moving average is $79.36. The firm has a market capitalization of $3.65 billion, a price-to-earnings ratio of 26.52, a PEG ratio of 1.91 and a beta of 0.58.

Merit Medical Systems (NASDAQ:MMSI) last issued its earnings results on Thursday, April 30th. The medical instruments supplier reported $0.94 earnings per share for the quarter, topping analysts’ consensus estimates of $0.84 by $0.10. Merit Medical Systems had a return on equity of 13.54% and a net margin of 9.03%.The company had revenue of $381.88 million for the quarter, compared to analyst estimates of $377.59 million. During the same period in the prior year, the firm earned $0.86 earnings per share. Merit Medical Systems’s revenue for the quarter was up 7.4% on a year-over-year basis. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. Sell-side analysts forecast that Merit Medical Systems, Inc. will post 3.61 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on the company. BTIG Research assumed coverage on Merit Medical Systems in a research note on Friday, February 6th. They issued a “buy” rating and a $107.00 price target on the stock. Wells Fargo & Company dropped their price target on Merit Medical Systems from $78.00 to $74.00 and set an “equal weight” rating on the stock in a research note on Friday, May 1st. Needham & Company LLC dropped their price target on Merit Medical Systems from $101.00 to $90.00 and set a “buy” rating on the stock in a research note on Friday, May 1st. Citigroup reissued an “outperform” rating on shares of Merit Medical Systems in a research note on Monday, April 20th. Finally, Compass Point set a $107.00 price target on Merit Medical Systems in a research note on Monday, April 20th. Eight research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $92.80.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.